Literature DB >> 28550936

The bare necessities? A realist review of necessity argumentations used in health care coverage decisions.

Tineke Kleinhout-Vliek1, Antoinette de Bont2, Bert Boer2.   

Abstract

CONTEXT: Policy makers and insurance companies decide on coverage of care by both calculating (cost-) effectiveness and assessing the necessity of coverage. AIM: To investigate argumentations pertaining to necessity used in coverage decisions made by policy makers and insurance companies, as well as those argumentations used by patients, authors, the public and the media.
METHODS: This study is designed as a realist review, adhering to the RAMESES quality standards. Embase, Medline and Web of Science were searched and 98 articles were included that detailed necessity-based argumentations.
RESULTS: We identified twenty necessity-based argumentation types. Seven are only used to argue in favour of coverage, five solely for arguing against coverage, and eight are used to argue both ways. A positive decision appears to be facilitated when patients or the public set the decision on the agenda. Moreover, half the argumentation types are only used by patients, authors, the public and the media, whereas the other half is also used by policy makers and insurance companies. The latter group is more accepted and used in more different countries.
CONCLUSION: The majority of necessity-based argumentation types is used for either favouring or opposing coverage, and not for both. Patients, authors, the public and the media use a broader repertoire of argumentation types than policy makers and insurance companies.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Decision-making; Health care coverage; Necessary health care

Mesh:

Year:  2017        PMID: 28550936     DOI: 10.1016/j.healthpol.2017.04.011

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  6 in total

1.  Under careful construction: combining findings, arguments, and values into robust health care coverage decisions.

Authors:  T H Kleinhout-Vliek; A A De Bont; A Boer
Journal:  BMC Health Serv Res       Date:  2022-06-07       Impact factor: 2.908

Review 2.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

3.  Around the Tables - Contextual Factors in Healthcare Coverage Decisions Across Western Europe.

Authors:  Tineke Kleinhout-Vliek; Antoinette de Bont; Meindert Boysen; Matthias Perleth; Romke van der Veen; Jacqueline Zwaap; Bert Boer
Journal:  Int J Health Policy Manag       Date:  2020-09-01

4.  What influences the outcome of active disinvestment processes in healthcare? A qualitative interview study on five recent cases of active disinvestment.

Authors:  Adriënne H Rotteveel; Mattijs S Lambooij; Joline J A van de Rijt; Job van Exel; Karel G M Moons; G Ardine de Wit
Journal:  BMC Health Serv Res       Date:  2021-04-01       Impact factor: 2.655

5.  Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases.

Authors:  Conor M W Douglas; Fernando Aith; Wouter Boon; Marina de Neiva Borba; Liliana Doganova; Shir Grunebaum; Rob Hagendijk; Larry Lynd; Alexandre Mallard; Faisal Ali Mohamed; Ellen Moors; Claudio Cordovil Oliveira; Florence Paterson; Vanessa Scanga; Julino Soares; Vololona Raberharisoa; Tineke Kleinhout-Vliek
Journal:  Orphanet J Rare Dis       Date:  2022-09-05       Impact factor: 4.303

6.  Implementing pharmaceutical track-and-trace systems: a realist review.

Authors:  Joeke Kootstra; Tineke Kleinhout-Vliek
Journal:  BMJ Glob Health       Date:  2021-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.